Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness
Year: 2026
Type: article
Abstract: differentiation, in part through a transcriptional program associated with Foxo1, thereby improving the efficacy of ACT. These findings identify NR as a promising and translatable metabolic adjuvant for HCC immunotherapy.
Source: Molecular Therapy
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7163196006
